MARKET

GENE

GENE

Genetic Technologies
NASDAQ
0.8520
+0.0669
+8.52%
After Hours: 0.8501 -0.0019 -0.22% 18:23 07/26 EDT
OPEN
0.7870
PREV CLOSE
0.7851
HIGH
0.8830
LOW
0.7700
VOLUME
68.76K
TURNOVER
0
52 WEEK HIGH
4.730
52 WEEK LOW
0.7500
MARKET CAP
2.74M
P/E (TTM)
-0.7132
1D
5D
1M
3M
1Y
5Y
1D
Cannabis Stock Gainers And Losers From July 23, 2024
Benzinga · 3d ago
Marijuana Stock Movers For July 22, 2024
Leafbuyer Techs shares closed up 3900.00% at $0.02. Heritage Cannabis Holding (OTC:HERTF) shares up 125.00%. Pharmadrug shares closed down 31.25%. Aurora Cannabis (NASDAQ:ACB) shares also closed up.
Benzinga · 4d ago
Weekly Report: what happened at GENE last week (0715-0719)?
Weekly Report · 4d ago
Genetic Technologies Appoints Mark Ziirsen As Chief Financial Officer
Genetic Technologies Limited appoints Mark Ziirsen as Chief Financial Officer and Company Secretary. Mark is a globally experienced ASX and Nasdaq listed CFO and company secretary with more than 25 years' experience. Genetic Technologies Limited is a global leader in genomics-based tests in health, wellness and serious disease.
Benzinga · 07/16 12:02
BRIEF-Genetic Technologies Announces Appointment Of Chief Financial Officer & Company Secretary
Reuters · 07/16 12:00
Cannabis Stock Gainers And Losers From July 15, 2024
Australis Capital shares closed up 9900.00% at $0.01. Global Hemp Group (OTC:GBHPF) shares up 70.36%. Canopy Gwth and Urban-gro shares up 3.33%. Elixinol Wellness shares closed down 20.00%.
Benzinga · 07/15 20:30
Weekly Report: what happened at GENE last week (0708-0712)?
Weekly Report · 07/15 10:44
Cannabis Stock Movers For July 12, 2024
Zelira Therapeutics (OTC:ZLDAF) shares closed up 69.95% at $0.48. Global Hemp Group and Eastside Distilling share closed up 40.00%. CLS Holdings USA shares closed down 27.84% in the last day.
Benzinga · 07/12 20:30
More
About GENE
Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its geneType and EasyDNA brands. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The Company operates through three segments: EasyDNA, AffinityDNA, and GeneType / Corporate. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses. GeneType / Corporate segment relates to geneType branded test sales and expenses, including corporate charges. The GeneType test is for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and mor

Webull offers Genetic Technologies Limited (ADR) stock information, including NASDAQ: GENE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GENE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GENE stock methods without spending real money on the virtual paper trading platform.